Background: Inducible laryngeal obstruction, an induced, inappropriate narrowing of
assessment, questionnaire scores and comorbidity burden were not sufficiently discriminatory for diagnosis, highlighting the necessity of objective diagnostic testing.
K E Y W O R D S
asthma, inducible laryngeal obstruction, larynx, mannitol, paradoxical vocal fold motion
| INTRODUCTION
Inducible laryngeal obstruction (ILO) is characterized by recurrent variable airflow obstruction in the larynx. It is an umbrella term for any triggered laryngeal obstruction occurring at either the supraglottic (arytenoid region, epiglottis or false vocal folds) and/or glottic (true vocal folds) level of the larynx and includes the condition also known as paradoxical vocal fold motion disorder (PVFM), or vocal cord dysfunction (VCD). 1, 2 Traditionally, the gold standard for diagnosis has been the demonstration on direct laryngoscopy of abnormal (hence paradoxical) adduction of the vocal folds during the respiratory cycle accompanying a symptomatic episode. 3 Although patients with symptoms and signs suggestive of ILO were described as early as 1885 4 advances in this field may have been hindered in part by a belief that the condition was psychosomatic in origin. 1 More recently, ILO has been considered as part of a spectrum of laryngeal dysfunction, which also includes chronic cough, globus pharyngeus and muscle tension dysphonia. All are thought to share a common pathophysiological pathway of laryngeal hypersensitivity, or "irritable larynx." 5, 6 Confusingly, ILO and asthma share many common symptoms, such as dyspnoea, chest tightness and wheeze. Distinguishing between the two conditions may be challenging and validated diagnostic and treatment algorithms have not yet been established.
Compounding this difficulty, asthma and ILO are not mutually exclusive. A high proportion of patients with difficult-to-treat asthma may have comorbid ILO, 7 with a reported prevalence of ILO in this population of between 30% and 50%. 8, 9 Patients with asthma and concurrent ILO are more likely to have poor quality of life and increased healthcare utilization. 10 Importantly, the treatment modalities for asthma and ILO are vastly different.
Our centre provides a difficult asthma service which focuses heavily on comorbidity assessment, including ILO. 11, 12 As an extension of this service, we developed a multidisciplinary Middle Airway
Clinic to systematically assess and manage patients with suspected concurrent asthma and ILO. We report the clinical characteristics and objectively determined diagnoses of a consecutive series of patients undergoing systematic evaluation.
| ME TH ODS
Our centre is a 600 bed tertiary hospital in Melbourne, Australia.
The Middle Airway Clinic was established in May 2015 specifically for the diagnosis and management of patients with concurrent suspected diagnoses of inducible laryngeal obstruction and asthma.
Patients were referred by specialists, either from the respiratory and allergy units, or from the Ear, Nose and Throat surgical unit. All patients underwent systematic assessment by a laryngologist, speech pathologist and respiratory physician. This report was approved by the Alfred Health Ethics committee (Reference number 37/16). Table S1 ).
| Multidisciplinary assessment
Laryngologist evaluation (PP, AR) comprised an ENT history and examination followed by flexible laryngoscopy to assess for paradoxical vocal fold motion, both at rest and following provocation manoeuvres. Any inducible laryngeal obstruction was classified, when possible, by location (supraglottic, glottic or both) and phase of respiratory cycle (inspiratory, expiratory or both) as described in recent consensus statements. 
| Comorbidity assessment
Patients were assessed for the presence of eight comorbidities: obesity, allergic rhinitis, chronic rhinosinusitis, gastroesophageal reflux disease, obstructive sleep apnoea, anxiety, depression and dysfunctional breathing. Comorbidity diagnosis was assisted by a battery of validated questionnaires ( 3 | RESULTS
| Patients included
Sixty-nine consecutive patients were assessed between 1 May 2015 and 1 February 2017 with the suspicion of co-existing inducible laryngeal obstruction and asthma. Thirty-one patients (45%) were referred from the difficult asthma service, 35 (51%) from general respiratory/allergy clinics and three (5%) from the general ear, nose and throat clinic. Baseline demographics are presented in Table 1 .
| Assessment procedures
All 69 patients underwent clinical assessment. All but one patient (who declined) completed the questionnaire battery. All but one (who declined) underwent spirometry. Sixty-seven patients underwent flexible nasoendoscopy AE stroboscopy, of whom 42 patients had nasoendoscopy performed as part of a mannitol challenge test.
Two patients did not undergo nasoendoscopy; one patient declined In patients with ILO, the median time to diagnosis was 5.5 years.
Eleven patients (27.5%) described an incident at onset, including nine triggered by respiratory infection (22.5%), one (2.5%) with environmental irritant exposure and one reportedly triggered following a general anaesthetic. Over half of all patients had presented to the emergency department with symptoms (62.5%). Inhaled odours (55%), exercise (57.5%) and psychological stress (57.5%) were common triggers for symptoms. An additional third of patients described triggers in their workplace including: cleaning products, chlorine, chalk dust, dust, singing, voice use and work-related stress.
Forty-four of 69 patients (64%) were diagnosed with definite asthma, with proven variable airflow obstruction. Of these, 19 (43%) patients had reversibility on spirometry, 6 (13.6%) patients had peak flow variability and 19 (43%) had positive bronchial provocation challenges.
| Co-existence of ILO and asthma
The total numbers of patients with or without ILO and asthma are shown in Table 2 .
| Patients without asthma or ILO (AÀIÀ)
Of the 14 patients with neither objectively demonstrable ILO nor asthma, one had globus pharyngeus and vocal cord paresis, two had chronic cough with laryngeal hypersensitivity, one had post-nasal drip due to chronic rhinitis and one had laryngeal hypersensitivity associated with recurrent upper airway angioedema. The remaining nine patients were still thought to have either probable ILO or asthma based on clinical assessment, but neither could be proven objectively. Of these 14 patients, nine were on inhaled corticosteroids for suspected asthma. Following evaluation, six of these nine patients had their inhaled corticosteroids ceased and an additional patient had the dose of inhaled corticosteroids reduced. Two patients were thought to have well-controlled asthma and thus were continued on their prescribed treatment.
| Patients with asthma only (A+I-)
Of the 15 patients with asthma but not ILO, five were thought to have symptoms attributable only to asthma. Another six patients had additional contributors to symptoms; two had dysfunctional breathing, one had angioedema and three had an irritable larynx in the context of high-dose inhaled corticosteroid treatment for asthma. The remaining four patients were treated for symptoms of ILO based on clinical assessment. As a direct result of the clinic evaluation, three patients were commenced on inhaled corticosteroids for uncontrolled asthma, while the other patients had their existing asthma treatment adjusted as per treatment guidelines.
| Patients with ILO only (AÀI+)
Eleven patients were classified as having ILO only. Six of these patients had been on high dose inhaled corticosteroids or combination therapy for asthma. One patient was found to have COPD. The remaining four patients were using intermittent short acting bron- 
| Patients with both asthma and ILO (A+I+)
Of the 29 patients with both ILO and asthma, the managing clinician's impression was that ILO predominantly contributed to symptoms in 41%, while asthma predominantly contributed to symptoms in 24%; dual contribution occurred in 14% (Figure 1) . Management of these patients included speech therapy and/or titration of asthma treatment according to recognized guidelines (GINA).
| Comparison between groups
When patients with both ILO and asthma (A+I+) were compared to patients with only ILO (AÀI+), chest tightness was significantly more common in patients with both ILO and asthma (P = .01) than in those with ILO alone. Forced expiratory ratio was also significantly higher in patients with ILO alone when compared to patients with both asthma and ILO (P = .009) (Figures 2 and 3 ).
There was a statistically significant difference in forced expira- When patients with both ILO and asthma (A+I+) were compared to patients with asthma alone (A+IÀ), patients with asthma alone had a lower FEV 1 (mean 81% vs 67%, P = .05), (Figure 4 ), while those with both ILO and asthma reported stridor more frequently (P = .012) (Figure 2 ).
When patients with asthma alone were compared to patients with ILO alone, FEV 1 was significantly lower in those with asthma (mean 94.3% vs 66.9%, P = .003). Similarly, the forced expiratory ratio was significantly lower in patients with asthma alone (mean 83% vs 64%, P < .001). Cough was found to be a more prominent feature in patients with asthma rather than ILO (P = .047). Difficulty with inspiration rather than expiration was more commonly seen in the ILO only group (P = .036). The presence of psychological stress as a trigger for symptoms was also more commonly seen in the ILO only patient group (P = .02). There were no significant differences in frequency of throat symptoms, voice change or vocally traumatic behaviours. (See Table 3 and Figure 2 ).
Laryngeal dysfunction questionnaire results were not discriminatory in our sample of patients, with abnormal scores seen in patients who had asthma and ILO, as well as patients who had asthma alone (Table S1 ).
| Comorbidities accompanying ILO and asthma
In addition to asthma, rhinitis (85%) and gastroesophageal reflux disease (75%) were common comorbidities in the overall cohort. On (Table S2 ).
| DISCUSSION
In our patients suspected to have asthma, inducible laryngeal obstruction, or both, almost half had objective evidence of both conditions. Achieving accurate diagnosis was extremely challenging. with stable asthma. As a direct result of our evaluation process, 16
patients had a change to prescribed asthma treatment, either commencing inhaled corticosteroids for uncontrolled asthma or weaning and ceasing inappropriate treatment, often with significant improvements to laryngeal symptoms. These outcomes illustrate the importance of clarifying these two diagnoses.
Our data suggest that many patients with ILO do not fit the previously reported typical profile. Firstly, previous investigators 27, 28 have suggested the typical patient with ILO is a female between the second and fourth decades of life with or without a psychological disorder. 29 While our patients were predominantly female, we found a much wider age range. It is true that psychological stress was identified as a trigger for symptoms more commonly in the patients with ILO, but anxiety, depression and dysfunctional breathing were seen with similar prevalence across all our patient groups.
Secondly, ILO has been reported to have a higher prevalence among healthcare workers and other occupations where exposure to a variety of irritant chemicals, dusts, mists and fumes may increase risk. 28, [30] [31] [32] Although some of our patients had identifiable occupational risk factors, the majority of patients did not. We Specific comorbidities such as chronic rhinitis and gastroesophageal reflux were highly prevalent in our cohort. While they did not distinguish between asthma and ILO, they may serve to trigger both conditions and if detected, should be treated aggressively. 9, 27, 34, 35 Most authors suggest that formal diagnosis of ILO should be supported where possible by direct visualization of paradoxical vocal fold movement 3, 6 as well as the exclusion of alternative diagnoses.
Our data show the unreliability of clinical evaluation and support the need for objective testing with direct visualization of ILO in all patients. Fibreoptic laryngoscopy has been criticized as being operator dependent and subjective 36 with a reduced sensitivity if the patient is not experiencing symptoms at the time of examination.
Nevertheless at this time, laryngoscopy remains the gold standard for diagnosis. Other methods such as impulse oscillometry 37 and 320 slice CT 38 have considerable drawbacks, due to their limited availability and radiation exposure required, respectively.
Numerous provocation techniques have been used to elicit ILO for diagnosis. Agents have included methacholine, exercise, cold air and irritant challenges, although the sensitivity of these challenges are <50%. 39 Over half of our patients reported exercise as a trigger for their symptoms, but we were unable to undertake exercise provocation at our centre.
We used mannitol, a dry powder inhalant, and have previously reported the ability of mannitol to induce ILO. 19 Direct provocation challenge with histamine or methacholine has traditionally been considered to be more sensitive but less specific for asthma diagnosis. 40, 41 We hypothesize that mannitol may be more effective as a laryngeal provoking agent due to its direct irritant effects on the upper airway, although we acknowledge its ability to induce laryngoscopically visualized ILO has not been compared to direct challenge agents. Other measurements obtained during bronchial provocation challenge testing, such as the mean decrease in forced inspiratory flow (%FIF 50 ) has not been found to be a reliable method of detecting (exercise induced) ILO. 42 The inclusion of mannitol provocation testing combined with laryngoscopy in our protocol doubled the detection rate for ILO. We therefore believe provocation testing to form an essential tool in the diagnostic work-up of suspected ILO.
The question as to whether ILO is a physiological consequence of severe asthma or a distinct clinical entity unto itself remains unresolved. 33, 36 Uniting mechanisms of airway inflammation and hyperresponsiveness have been suggested 8 as well as an observation of expiratory glottic closure during bronchoconstriction. This may be a compensatory mechanism to increase intrinsic positive end-expiratory pressure and improving alveolar gas exchange. 43, 44 However, in our sample, patients with ILO tended to have better lung function, less severe airflow obstruction; and both expiratory and inspiratory ILO were observed, suggesting that ILO was not solely due to airflow limitation or severe asthma.
In normal respiration, the glottic aperture should remain mostly open. Closure of the glottis is mediated by a neuronal reflex arc which may be triggered by proprioceptive, chemical or thermal stimuli. 6 We elected to use the definition of more than 50% adduction of the vocal folds during expiration in addition to any adduction during inspiration as an indicator of paradoxical movement as has been previously described. 27 We suggest this represents a hypersensitive response, especially as it only occurred in a subset of our cohort.
However, we acknowledge there is currently no validated measurement guideline to differentiate normal from abnormal laryngeal responses and the area requires further research. 2 Two patients in our series demonstrated supraglottic closure, which has been usually described in association with exercise provocation. As we did not undertake exercise provocation, supraglottic laryngeal obstruction may have been underdiagnosed in our cohort.
We recognize several limitations in our study. There was no control group to our observational series. Included patients were highly selected and had a high pre-test probability of some form of laryngeal dysfunction (including inducible laryngeal obstruction), limiting the generalizability of our findings. Detection of paradoxical movement of the vocal folds was by observation which may lead to inter-rater observer variability; although our previous work has demonstrated significant inter-rater agreement. 19 The limited statistical power due to our small sample size may have led to some non-significant results.
| CONCLUSION
Asthma and ILO commonly co-exist. We describe a systematic, multidisciplinary assessment process for the diagnosis of asthma and ILO when both conditions are suspected. In patients with both diagnoses, ILO appears to be more clinically symptomatic. In this selected series, laryngeal dysfunction questionnaires were non-discriminatory and a high comorbidity burden was seen in all patients; objective diagnostic testing is therefore essential. Further longitudinal studies evaluating patient outcomes following such diagnosis and assessment processes are warranted.
